FDA flags 122,021-case Gatorade recall; UAE pharmacies should check imported stock

PepsiCo has recalled 122,021 cases of 28 oz Gatorade bottles in the U.S. after labels failed to declare Yellow No. 5 and/or Yellow No. 6, according to the U.S. Food and Drug Administration (FDA) enforcement notice reported by CBS News and other U.S. outlets.

The story matters in the UAE because sports drinks are sold through supermarkets, gyms, clinics and pharmacy-adjacent retail channels, and some UAE consumers buy U.S. stock through online importers. For Dubai operators, the immediate task is an inventory and supplier-origin check. The Dubai Health Authority (DHA) regulates licensed healthcare facilities in Dubai, while Department of Health Abu Dhabi (DOH Abu Dhabi) covers Abu Dhabi and Al Ain healthcare providers, and Ministry of Health and Prevention (MOHAP) covers Northern Emirates healthcare licensing and federal health matters. Food retail and import controls may also involve municipal and economy channels, so pharmacies should separate clinical reporting from consumer-product stock control.

What was recalled

The FDA classified the recall as Class II on 2 October 2026, after PepsiCo initiated it on 25 September 2026. The affected products are Gatorade Lemon Lime, Gatorade Lemon Lime Zero, Gatorade Orange and Gatorade Orange Zero in 28 oz bottles, with lot dates in April 2027, May 2027 and June 2027, according to ABC News. Distribution was reported across 37 U.S. states.

Class II means exposure may cause temporary or medically reversible adverse health consequences, with serious harm remote. FDA classification, 2 October 2026.

PepsiCo said the issue was a label discrepancy affecting a limited number of 28 oz single-serve products. Its Gatorade contact page states that the ingredient panel did not declare Yellow 5 on Lemon Lime products and Yellow 6 on Orange products, according to PepsiCo. This is a labelling recall, not a reported infection outbreak.

What UAE operators should check

Dubai clinics, gyms attached to medical centres and pharmacy chains should first identify whether they hold U.S.-labelled 28 oz bottles. The common UAE retail pack is smaller. Carrefour UAE listed Gatorade Fruit Punch 495 ml at AED 4.99 last week, while Lulu UAE listed Gatorade Tropical Fruit 500 ml at AED 7.70, giving operators a live retail reference point rather than a recall-cost estimate. Bulk buyers should use invoice price, supplier name, SKU, lot date and country of origin to calculate exposure.

• Pull 28 oz Lemon Lime, Lemon Lime Zero, Orange and Orange Zero bottles for lot-date review.
• Ask suppliers to confirm whether stock came through U.S. distribution or UAE-authorised channels.
• Log any patient complaint involving rash, wheeze, asthma-type symptoms or known dye sensitivity.
• Keep receipts and invoices for insurer or supplier reimbursement discussions.

For insurers such as Daman, Thiqa and Sukoon, the likely exposure is small unless a member seeks care after suspected ingestion. The practical issue is documentation. Claims teams should ask for the product photo, lot date, purchase channel and clinical note. Clinics should code the visit by presenting symptoms and document the suspected product separately, rather than treating the recall notice as proof of causation.

Patient advice and next steps

Medical directors should give a narrow message. Patients with known sensitivity to colour additives, aspirin hypersensitivity or asthma-type reactions should avoid the affected U.S. lots and seek care if symptoms appear. Patients who drank a UAE-sourced 495 ml or 500 ml bottle without symptoms do not need emergency review based on the U.S. notice alone.

For pharmacy leaders, the next 48 hours should be enough to complete a shelf and store-room check if purchasing records are searchable by SKU and supplier. Dubai providers should keep DHA compliance files current. Abu Dhabi and Al Ain providers should retain the same records for DOH Abu Dhabi inspection. Northern Emirates providers should retain records for MOHAP-linked licensing and inspection pathways.

Patients and clinic procurement teams looking for licensed pharmacy providers can use the UAE Open Healthcare Directory, which lists 1,680 pharmacy providers and wider licensed healthcare facilities across Dubai, Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah, Umm Al Quwain and Al Ain.